Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Payables (2018 - 2026)

Profound Medical has reported Payables over the past 8 years, most recently at $1.6 million for Q4 2025.

  • For Q4 2025, Payables rose 18.68% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, up 18.68%, while the annual FY2025 figure was $1.6 million, 18.68% up from the prior year.
  • Payables for Q4 2025 was $1.6 million at Profound Medical, up from $717000.0 in the prior quarter.
  • Over five years, Payables peaked at $3.2 million in Q4 2021 and troughed at -$739000.0 in Q2 2022.
  • A 5-year average of $927950.0 and a median of $907000.0 in 2023 define the central range for Payables.
  • Biggest five-year swings in Payables: surged 122482.14% in 2021 and later crashed 2814.29% in 2024.
  • Year by year, Payables stood at $3.2 million in 2021, then tumbled by 36.07% to $2.0 million in 2022, then crashed by 57.45% to $865000.0 in 2023, then soared by 52.25% to $1.3 million in 2024, then grew by 18.68% to $1.6 million in 2025.
  • Business Quant data shows Payables for PROF at $1.6 million in Q4 2025, $717000.0 in Q3 2025, and $949000.0 in Q2 2025.